|
2004 Conference Publication Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.Tate, JR, Mollee, P and Gill, D (2004). Serum free light chain ratios do not detect relapse in some patients with intact immunoglobulin myeloma post autologous peripheral blood stem cell transplantation.. 56th Annual Meeting of the American-Association-for-Clinical-Chemistry, Los Angeles Ca, Jul 25-29, 2004. WASHINGTON: AMER ASSOC CLINICAL CHEMISTRY. |
|
2004 Journal Article Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemiaMollee, P., Gupta, V., Song, K., Reddy, V., Califaretti, N., Tsang, R., Crump, M. and Keating, A. (2004). Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia. Bone Marrow Transplantation, 33 (12), 1201-1208. doi: 10.1038/sj.bmt.1704506 |
|
2004 Journal Article Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcomeMollee, P. N., Wechalekar, A. D., Pereira, D. L., Franke, N., Reece, D., Chen, C. and Stewart, A. K. (2004). Autologous stem cell transplantation in primary systemic amyloidosis: the impact of selection criteria on outcome. Bone Marrow Transplantation, 33 (3), 271-277. doi: 10.1038/sj.bmt.1704344 |
|
2004 Journal Article Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemiaMollee, P., Arthur, C., Hughes, T., Januszewicz, H., Grigg, A., Bradstock, K., Wolf, M., Gibson, J., Schwarer, A. P., Spencer, A., Browett, P., Hawkins, T., Seldon, M., Herrmann, R. and Watson, A. (2004). Interferon-α-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. Annals of Oncology, 15 (12), 1810-1815. doi: 10.1093/annonc/mdh468 |
|
2003 Conference Publication The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.Mollee, PN, Mills, AK, Grimmett, K, Van Kuilenburg, R, Saal, RJ, Gill, D, Cobcroft, R and Marlton, P (2003). The impact of the hyper-CVAD chemotherapy regimen on the ability to mobilize peripheral blood stem cells (PBSC) in patients with hematological malignancies.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego, CA, United States, 6-9 December 2003. Washington, DC, United States: American Society of Hematology. |
|
2003 Journal Article Measurement of immunoglobulin free light chains in serum - ReplyTate, JR, Mollee, P and Gill, D (2003). Measurement of immunoglobulin free light chains in serum - Reply. Clinical Chemistry, 49 (11), 1958-1958. doi: 10.1373/clinchem.2003.026294 |
|
2003 Journal Article Why aren’t we performing more allografts for aggressive non-Hodgkin’s lymphoma?Mollee, P., Lararus, H. M. and Lipton, J. (2003). Why aren’t we performing more allografts for aggressive non-Hodgkin’s lymphoma?. Bone Marrow Transplantation, 31 (11), 953-960. doi: 10.1038/sj.bmt.1704040 |
|
2003 Journal Article Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtypeSong, Kevin W., Mollee, Peter, Keating, Amanda and Crump, Michael (2003). Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. British Journal of Haematology, 120 (6), 978-985. doi: 10.1046/j.1365-2141.2003.04203.x |
|
2002 Conference Publication Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.Mollee, P, Nagy, T, Saragosa, R, Turner, R, Keating, A and Crump, M (2002). Effect of gemcitabine, dexamethasone and cisplatin salvage chemotherapy (GDP) on peripheral blood stem cell (PBSC) mobilization in patients with lymphoma.. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Conference Publication Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).Mollee, P, Gupta, V, Song, K, Tsang, R, Crump, M and Keating, A (2002). Long-term outcome following high-dose therapy with etoposide, melphalan, TBI and autologous stem cell transplantation (ASCT) for acute myeloid leukemia (AML).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. |
|
2002 Conference Publication Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).Mollee, P, Song, K, Keating, A, Tsang, R and Crump, M (2002). Autologous stem cell transplantation (ASCT) for relapsed/refractory follicular large cell lymphoma (FLCL).. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, Dec 06-10, 2002. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2002 Journal Article Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphomaSong, KW, Mollee, P, Patterson, B, Brien, W and Crump, M (2002). Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B-cell lymphoma. British Journal of Haematology, 119 (1), 125-127. doi: 10.1046/j.1365-2141.2002.03778.x |
|
2002 Journal Article Progenitor cell mobilisation - Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphomaMollee, P, Pereira, D, Nagy, T, Song, K, Saragosa, R, Keating, A and Crump, M (2002). Progenitor cell mobilisation - Cyclophosphamide, etoposide and G-CSF to mobilize peripheral blood stem cells for autologous stem cell transplantation in patients with lymphoma. Bone Marrow Transplantation, 30 (5), 273-278. doi: 10.1038/sj.bmt.1703653 |
|
2002 Conference Publication Allogeneic stem cell transplantation for idiopathic myelofibrosis in AustralasiaDurrant, S, Szer, J, Bradstock, K, Nivison-Smith, I and Mollee, P (2002). Allogeneic stem cell transplantation for idiopathic myelofibrosis in Australasia. 23rd Annual Scientific Meeting of the Transplantation-Society-of-Australia-and-New-Zealand, Canberra Australia, May 11-13, 2005. LONDON: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.Keating, A, Filshie, R, Mollee, P and Wang, XH (2001). Prolonged engraftment and transgene expression of genetically modified autologous bone marrow stromal (mesenchymal) cells after infusion post autotransplant: A platform for cell and gene therapy.. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2001 Journal Article Single institution outcomes of treatment of severe aplastic anaemiaMollee, P., Woodward, N., Durrant, S., Lockwood, L., Gillett, E. A., Morton, J. and Rowell, J. (2001). Single institution outcomes of treatment of severe aplastic anaemia. Internal Medicine Journal, 31 (6), 337-342. doi: 10.1046/j.1445-5994.2001.00078.x |
|
2001 Journal Article Single institution outcomes of treatment of severe aplastic anaemiaMollee, P., Woodward, N., Durrant, S., Lockwood, L., Gillett, E. A., Morton, J. and Rowell, J. (2001). Single institution outcomes of treatment of severe aplastic anaemia. Internal Medicine Journal, 31 (6), 337-342. doi: 10.1046/j.1445-5994.2001.00078.x |
|
2001 Conference Publication Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantationIrving, I, Williamson, J, Mollee, P, Morton, AJ, Sloots, T, Siebert, D and Durrant, S (2001). Low dose valaciclovir for the prevention of CMV disease post allogeneic bone marrow transplantation. BASINGSTOKE: NATURE PUBLISHING GROUP. |
|
2001 Conference Publication Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.Durrant, S., Irving, I., Mollee, P., Morton, A. J., Webb, M. and Macfarlane, D. (2001). Phase I/II study of Sm-153 lexidronam, limb irradiation and stem cell transplantation for the treatment of multiple myeloma.. 27th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, United Kingdom: Nature Publishing Group. |
|
2000 Conference Publication Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.Mollee, P, Morton, J, Irving, I and Durrant, S (2000). Combination therapy with antithymocyte globulin (ATG) and tacrolimus for patients with steroid refractory GVHD.. |
